Švýcarsko -
italština -
Swissmedic (Swiss Agency for Therapeutic Products)
capecitabin-teva 150 mg compresse rivestite con film
teva pharma ag - capecitabinum - compresse rivestite con film - capecitabinum 150 mg, lactosum 15.6 mg, cellulosum microcristallinum, hypromellosum, carmellosum natricum conexum corresp. natrium 0.59 mg, magnesii stearas, Überzug: hypromellosum, macrogolum 400, e 171, e 172 (flavum), e 172 (rubrum), pro compresso obducto. - farmaco - synthetika
Švýcarsko -
italština -
Swissmedic (Swiss Agency for Therapeutic Products)
capecitabin-teva 500 mg compresse rivestite con film
teva pharma ag - capecitabinum - compresse rivestite con film - capecitabinum 500 mg, lactosum 52 mg, cellulosum microcristallinum, hypromellosum, carmellosum natricum conexum corresp. natrium 1.71 mg, magnesii stearas, Überzug: hypromellosum, e 171, macrogolum 400, e 172 (flavum), e 172 (rubrum), pro compresso obducto. - farmaco - synthetika
Švýcarsko -
italština -
Swissmedic (Swiss Agency for Therapeutic Products)
mvasi 100 mg/4 ml concentrato per soluzione per infusione
amgen switzerland ag - bevacizumabum - concentrato per soluzione per infusione - bevacizumabum 100 mg, trehalosum dihydricum, natrii dihydrogenophosphas monohydricus, dinatrii phosphas, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 4 ml corresp. natrium 5.42 mg. - onkologikum - biotechnologika
Švýcarsko -
italština -
Swissmedic (Swiss Agency for Therapeutic Products)
mvasi 400 mg/16 ml concentrato per soluzione per infusione
amgen switzerland ag - bevacizumabum - concentrato per soluzione per infusione - bevacizumabum 400 mg, trehalosum dihydricum, natrii dihydrogenophosphas monohydricus, dinatrii phosphas, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 16 ml corresp. natrium 21.68 mg. - onkologikum - biotechnologika